Ortho Kinematics closes $2 million of new funding

Ortho Kinematics, a privately held spine diagnostics company focused on revolutionizing spine motion analysis announced today the close of $2 million of new funding. TEXO Ventures led the investment, which also included participation by both original investors, PTV Sciences, and Gatebridge Investments.

These new funds will enable the company to expand its ongoing clinical study of the KineGraph VMA™ (Vertebral Motion Analyzer) technology, pursue regulatory clearance, and hire key sales personnel.

Ortho Kinematics is developing the KineGraph VMA™ technology for analyzing spinal motion, which is currently in clinical studies at seven sites across the United States and United Kingdom.

The KineGraph VMA is a proprietary technology platform that is designed to be used in conjunction with standard fluoroscopy, which is commonly available in hospitals and clinics. Video images are captured of the spine in motion while patients are guided through a series of flexion, extension, and side-bending movements. Proprietary image recognition software is designed to track the intervertebral movement to produce information about the movement at each vertebral level. This information is intended to provide spine clinicians and researchers with data to assist in assessing spine pain patients. At this time the KineGraph VMA is an investigational device that has not received marketing clearance or approval from the U.S. FDA or foreign regulatory authorities and is not available for commercial sale.

Reginald J. Davis, M.D., a renowned neurosurgeon with Greater Baltimore Neurological Associates in Baltimore, Maryland comments, "The spine industry would benefit from functional diagnostic testing to help clinicians better understand patient treatment options. Ortho Kinematics' clinical evaluations may help us, as spine researchers and surgeons, better understand spine motions. Their test offers the potential for the spine community to gain rich, in vivo insights into spine pain."

Adam Deitz, CEO and Founder of Ortho Kinematics, said that, "The confidence investors have shown us with this latest investment is a testament to the company's potential. The capital and collaboration provided by our investors will support our ambitious growth plans."